Historical valuation data is not available at this time.
abrdn China Investment Company Limited (ACIC.L) is a closed-end investment company focused on providing investors with long-term capital growth through exposure to Chinese equities. The fund primarily invests in a diversified portfolio of Chinese companies, including A-shares, H-shares, and other Chinese securities listed domestically or internationally. Managed by abrdn (formerly Standard Life Aberdeen), the fund leverages the firm's expertise in emerging markets and China-specific investment strategies. ACIC.L aims to capitalize on China's economic growth, targeting sectors such as consumer, technology, and financial services. Its competitive advantage lies in abrdn's local research capabilities and long-standing presence in the region.
No specific R&D or patents; relies on abrdn's analytical tools and investment frameworks for China exposure.
ACIC.L offers targeted exposure to Chinese equities, benefiting from abrdn's regional expertise. However, it carries significant risks tied to China's regulatory environment and market volatility. Suitable for investors with high risk tolerance and a long-term horizon. Performance will hinge on China's economic trajectory and geopolitical stability.
abrdn China Investment Company Limited fact sheets, abrdn website, London Stock Exchange filings.